INS and hepatocellular carcinoma: The results indicated that tight junction, mTOR, insulin, PI3k-AKT, hepatocellular carcinoma, FoxO, and apoptosis pathways (p < 0.05) were the possible druggable signaling pathways of CVM-1125 (Figure 7B).